Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
03 2023
Historique:
received: 22 07 2022
accepted: 05 10 2022
pubmed: 18 11 2022
medline: 7 3 2023
entrez: 17 11 2022
Statut: epublish

Résumé

The primary aim of our study was to investigate the association between intubation timing and hospital mortality in critically ill patients with coronavirus disease 2019 (COVID-19)-associated respiratory failure. We also analysed both the impact of such timing throughout the first four pandemic waves and the influence of prior noninvasive respiratory support on outcomes. This is a secondary analysis of a multicentre, observational and prospective cohort study that included all consecutive patients undergoing invasive mechanical ventilation due to COVID-19 from across 58 Spanish intensive care units (ICUs) participating in the CIBERESUCICOVID project. The study period was between 29 February 2020 and 31 August 2021. Early intubation was defined as that occurring within the first 24 h of ICU admission. Propensity score matching was used to achieve a balance across baseline variables between the early intubation cohort and those patients who were intubated after the first 24 h of ICU admission. Differences in outcomes between early and delayed intubation were also assessed. We performed sensitivity analyses to consider a different time-point (48 h from ICU admission) for early and delayed intubation. Of the 2725 patients who received invasive mechanical ventilation, a total of 614 matched patients were included in the analysis (307 for each group). In the unmatched population, there were no differences in mortality between the early and delayed groups. After propensity score matching, patients with delayed intubation presented higher hospital mortality (27.3% In patients with COVID-19 requiring invasive mechanical ventilation, delayed intubation was associated with a higher risk of hospital mortality. The use of early intubation significantly decreased throughout the course of the pandemic. Benefits of such an approach occurred more notably in patients who had received HFNC.

Sections du résumé

BACKGROUND
The primary aim of our study was to investigate the association between intubation timing and hospital mortality in critically ill patients with coronavirus disease 2019 (COVID-19)-associated respiratory failure. We also analysed both the impact of such timing throughout the first four pandemic waves and the influence of prior noninvasive respiratory support on outcomes.
METHODS
This is a secondary analysis of a multicentre, observational and prospective cohort study that included all consecutive patients undergoing invasive mechanical ventilation due to COVID-19 from across 58 Spanish intensive care units (ICUs) participating in the CIBERESUCICOVID project. The study period was between 29 February 2020 and 31 August 2021. Early intubation was defined as that occurring within the first 24 h of ICU admission. Propensity score matching was used to achieve a balance across baseline variables between the early intubation cohort and those patients who were intubated after the first 24 h of ICU admission. Differences in outcomes between early and delayed intubation were also assessed. We performed sensitivity analyses to consider a different time-point (48 h from ICU admission) for early and delayed intubation.
RESULTS
Of the 2725 patients who received invasive mechanical ventilation, a total of 614 matched patients were included in the analysis (307 for each group). In the unmatched population, there were no differences in mortality between the early and delayed groups. After propensity score matching, patients with delayed intubation presented higher hospital mortality (27.3%
CONCLUSIONS
In patients with COVID-19 requiring invasive mechanical ventilation, delayed intubation was associated with a higher risk of hospital mortality. The use of early intubation significantly decreased throughout the course of the pandemic. Benefits of such an approach occurred more notably in patients who had received HFNC.

Identifiants

pubmed: 36396142
pii: 13993003.01426-2022
doi: 10.1183/13993003.01426-2022
pmc: PMC9686319
pii:
doi:

Types de publication

Observational Study Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©The authors 2023.

Déclaration de conflit d'intérêts

Conflicts of interest: O. Roca discloses a research grant from Hamilton Medical AG; speaker fees from Hamilton Medical AG, Ambu, Fisher & Paykel Ltd and Aerogen Ltd; and nonfinancial research support from Timpel and Masimo. R. Mellado-Artigas reports speaker fees from Medtronic and Fisher & Paykel, all outside the submitted work. The remaining authors declare no conflicts of interest.

Auteurs

Jordi Riera (J)

Critical Care Department, Hospital Universitari Vall d'Hebron, SODIR, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
These authors contributed equally to this work.

Enric Barbeta (E)

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Surgical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona (UB), Barcelona, Spain.
These authors contributed equally to this work.

Adrián Tormos (A)

Barcelona Supercomputing Center (BSC), Barcelona, Spain.

Ricard Mellado-Artigas (R)

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Surgical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

Adrián Ceccato (A)

Critical Care Center, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain.
Universitat Autonoma de Barcelona (UAB), Barcelona, Spain.

Anna Motos (A)

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona (UB), Barcelona, Spain.

Laia Fernández-Barat (L)

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona (UB), Barcelona, Spain.

Ricard Ferrer (R)

Critical Care Department, Hospital Universitari Vall d'Hebron, SODIR, Vall d'Hebron Institut de Recerca, Barcelona, Spain.

Darío García-Gasulla (D)

Barcelona Supercomputing Center (BSC), Barcelona, Spain.

Oscar Peñuelas (O)

Hospital Universitario de Getafe, Universidad Europea, Madrid, Spain.

José Ángel Lorente (JÁ)

Hospital Universitario de Getafe, Universidad Europea, Madrid, Spain.

Rosario Menéndez (R)

Pneumology Department, Hospital Universitario y Politécnico La Fe/Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain.

Oriol Roca (O)

Critical Care Department, Hospital Universitari Vall d'Hebron, SODIR, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.

Andrea Palomeque (A)

Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona (UB), Barcelona, Spain.
Respiratory Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

Carlos Ferrando (C)

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Surgical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

Jordi Solé-Violán (J)

Critical Care Department, Hospital Dr Negrín Gran Canaria, Universidad Fernando Pessoa, Las Palmas, Spain.

Mariana Novo (M)

Servei de Medicina Intensiva, Hospital Universitari Son Espases, Palma de Mallorca, Spain.

María Victoria Boado (MV)

Hospital Universitario de Cruces, Barakaldo, Spain.

Luis Tamayo (L)

Critical Care Department, Hospital Universitario Río Hortega de Valladolid, Valladolid, Spain.

Ángel Estella (Á)

Departamento Medicina, Facultad Medicina, Universidad de Cádiz, Hospital Universitario de Jerez, Jerez de la Frontera, Spain.

Cristóbal Galban (C)

Department of Medicine, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain.

Josep Trenado (J)

Servicio de Medicina Intensiva, Hospital Universitario Mútua de Terrassa, Terrassa, Spain.

Arturo Huerta (A)

Pulmonary and Critical Care Division, Emergency Department, Clínica Sagrada Família, Barcelona, Spain.

Ana Loza (A)

Hospital Virgen de Valme, Sevilla, Spain.

Luciano Aguilera (L)

Hospital de Basurto, Bilbao, Spain.

José Luís García Garmendia (JL)

Intensive Care Unit, Hospital San Juan de Dios del Aljarafe, Bormujos, Spain.

Carme Barberà (C)

Hospital Santa Maria, IRBLleida, Lleida, Spain.

Víctor Gumucio (V)

Department of Intensive Care, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Lorenzo Socias (L)

Intensive Care Unit, Hospital Son Llàtzer, Palma de Mallorca, Spain.

Nieves Franco (N)

Hospital Universitario de Móstoles, Madrid, Spain.

Luis Jorge Valdivia (LJ)

Hospital Universitario de León, León, Spain.

Pablo Vidal (P)

Complexo Hospitalario Universitario de Ourense, Ourense, Spain.

Víctor Sagredo (V)

Hospital Universitario de Salamanca, Salamanca, Spain.

Ángela Leonor Ruiz-García (ÁL)

Servicio de Microbiología Clínica, Hospital Universitario Príncipe de Asturias, Departamento de Biomedicina y Biotecnología, Universidad de Alcalá de Henares, Madrid, Spain.

Ignacio Martínez Varela (I)

Critical Care Department, Hospital Universitario Lucus Augusti, Lugo, Spain.

Juan López (J)

Complejo Asistencial Universitario de Palencia, Palencia, Spain.

Juan Carlos Pozo (JC)

UGC-Medicina Intensiva, Hospital Universitario Reina Sofia, Instituto Maimonides IMIBIC, Córdoba, Spain.

Maite Nieto (M)

Hospital Universitario de Segovia, Segovia, Spain.

José M Gómez (JM)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Aaron Blandino (A)

Servicio de Medicina Intensiva, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Manuel Valledor (M)

Hospital Universitario "San Agustín", Avilés, Spain.

Elena Bustamante-Munguira (E)

Department of Intensive Care Medicine, Hospital Clínico Universitario Valladolid, Valladolid, Spain.

Ángel Sánchez-Miralles (Á)

Servicio de Medicina Intensiva, Hospital Universitario Sant Joan d'Alacant, Alicante, Spain.

Yhivian Peñasco (Y)

Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

José Barberán (J)

Hospital Universitario HM Montepríncipe, Universidad San Pablo-CEU, Madrid, Spain.

Alejandro Ubeda (A)

Servicio de Medicina Intensiva, Hospital Punta de Europa, Algeciras, Spain.

Rosario Amaya-Villar (R)

Intensive Care Clinical Unit, Hospital Universitario Virgen de Rocío, Sevilla, Spain.

María Cruz Martín (MC)

Hospital Universitario Torrejón, Universidad Francisco de Vitoria, Madrid, Spain.

Ruth Jorge (R)

Intensive Care Department, Hospital Nuestra Señora de Gracia, Zaragoza, Spain.

Jesús Caballero (J)

Critical Care Department, Hospital Universitari Arnau de Vilanova, IRBLleida, Lleida, Spain.

Judith Marin (J)

Critical Care Department, Hospital del Mar-IMIM, Barcelona, Spain.

José Manuel Añón (JM)

Hospital Universitario la Paz, Madrid, Spain.

Fernando Suárez Sipmann (F)

Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain.

Guillermo M Albaiceta (GM)

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Departamento de Biología Funcional, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias, Hospital Central de Asturias, Oviedo, Spain.

Álvaro Castellanos-Ortega (Á)

Hospital Universitario y Politécnico la Fe, Valencia, Spain.

Berta Adell-Serrano (B)

Hospital de Tortosa Verge de la Cinta, Tortosa, Spain.

Mercedes Catalán (M)

Department of Intensive Care Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.

Amalia Martínez de la Gándara (A)

Hospital Universitario Infanta Leonor, Madrid, Spain.

Pilar Ricart (P)

Servei de Medicina Intensiva, Hospital Universitari Germans Trias, Badalona, Spain.

Cristina Carbajales (C)

Intensive Care Unit, Hospital Álvaro Cunqueiro, Vigo, Spain.

Alejandro Rodríguez (A)

Hospital Universitari Joan XXIII de Tarragona, Tarragona, Spain.

Emili Díaz (E)

Critical Care Center, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain.
Universitat Autonoma de Barcelona (UAB), Barcelona, Spain.

Mari C de la Torre (MC)

Hospital de Mataró de Barcelona, Barcelona, Spain.

Elena Gallego (E)

Unidad de Cuidados Intensivos, Hospital Universitario San Pedro de Alcántara, Cáceres, Spain.

Luisa Cantón-Bulnes (L)

Unidad de Cuidados Intensivos, Hospital Virgen Macarena, Sevilla, Spain.

Nieves Carbonell (N)

Intensive Care Unit, Hospital Clínico y Universitario de Valencia, Valencia, Spain.

Jessica González (J)

Translational Research in Respiratory Medicine, Respiratory Department, Hospital Universitari Aranu de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.

David de Gonzalo-Calvo (D)

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Translational Research in Respiratory Medicine, Respiratory Department, Hospital Universitari Aranu de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.

Ferran Barbé (F)

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Translational Research in Respiratory Medicine, Respiratory Department, Hospital Universitari Aranu de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.

Antoni Torres (A)

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain atorres@clinic.cat.
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona (UB), Barcelona, Spain.
Respiratory Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH